Risk assessment for ecotoxicity of pharmaceuticals an emerging issue

Expert Opinion on Drug Safety

Volumn 11, Issue 2, 2012, Pages 235-274

  Kar, Supratik ^a   Roy, Kunal ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

Ecotoxicity; in silico tools; Pharmaceuticals; QSTR

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTILIPEMIC AGENT; ANTINEOPLASTIC AGENT; ANTIPARASITIC AGENT; ANTIVIRUS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYTOSTATIC AGENT; DOMESTIC CHEMICAL; DRINKING WATER; DRUG; DRUG METABOLITE; ESTRADIOL; GROUND WATER; HERBACEOUS AGENT; INDUSTRIAL EFFLUENT; NONSTEROID ANTIINFLAMMATORY AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID; SURFACE WATER; VETERINARY DRUG;

AGRICULTURE; ANIMAL HUSBANDRY; ANTIBIOTIC RESISTANCE; AQUACULTURE; COMPUTER MODEL; COMPUTER PROGRAM; DRUG CONTROL; DRUG FECES LEVEL; DRUG LEGISLATION; DRUG URINE LEVEL; DUST; ECOTOXICITY; EFFLUENT; ENVIRONMENTAL FACTOR; FOOD AND DRUG ADMINISTRATION; GOOD MANUFACTURING PRACTICE; GOVERNMENT REGULATION; HEALTH CARE ORGANIZATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOUSEHOLD; HUMAN; JAPAN; MANURE; MASS FRAGMENTOGRAPHY; MEDICAL LITERATURE; NONHUMAN; PHYSICAL CHEMISTRY; PREDICTIVE VALUE; QUANTITATIVE STRUCTURE TOXICITY RELATIONSHIP; REFERENCE DATABASE; REVIEW; RISK ASSESSMENT; RISK MANAGEMENT; RISK REDUCTION; SEDIMENT; SLUDGE; SOIL ANALYSIS; SOLID PHASE EXTRACTION; STRUCTURE ACTIVITY RELATION; TANDEM MASS SPECTROMETRY; VETERINARY MEDICINE; WASTE WATER;

ANIMALS; DATABASES, FACTUAL; ECOSYSTEM; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; GOVERNMENT REGULATION; HUMANS; MODELS, THEORETICAL; MOLECULAR STRUCTURE; PHARMACEUTICAL PREPARATIONS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RISK ASSESSMENT; TOXICITY TESTS;

EID: 84857429258     PISSN: 14740338     EISSN: 1744764X     Source Type: Journal    
DOI: 10.1517/14740338.2012.644272     Document Type: Review

References (145)

1. Halling-Sørensen B, Nors Nielsen S, Lanzky PF, et al. Occurrence, fate and effects of pharmaceutical substances in the environment-a review. Chemosphere 1998;36(2):357-93 (Pubitemid 27514266)
2. Kummerer K. Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks. Springer-Verlag; Berlin: 2001
3. Cleuvers M. Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. Toxicol Lett 2003;142:185-94 (Pubitemid 36412007)
4. Seiler JP. Pharmacodynamic activity of drugs and Ecotoxicology can the two be connected? Toxicol Lett 2002;131(1-2):105-15
5. Zwiener C, Frimmel FH. Short-term tests with a pilot sewage plant and biofilm reactors for the biological degradation of the pharmaceutical compounds clofibric acid, ibuprofen, and diclofenac. Sci Total Environ 2003;309(1-3):201-11 (Pubitemid 36677580)
6. Daughton CG, Ternes TA. Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ Health Perspect 1999;107:907-37
7. Ternes TA, Bonerz M, Schmidt T. Determination of neutral pharmaceuticals in wastewater and rivers by liquid chromatography electrospray tandem mass spectrometry. J Chromatogr 2001;A 938:175-85 (Pubitemid 33145463)
8. Heberer Th, Dunnbier U, Reilich CH, et al. Detection of drugs and drug metabolites in ground water samples of a drinking water treatment plant. Fresenius Environ Bull 1997;6:438-43 (Pubitemid 27307391)
9. Kolpin DW, Furlong ET, Meyer MT, et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environ Sci Technol 2002;36(6):1202-11 (Pubitemid 34228893)
10. Adler P, Steger-Hartmann T, Kalbfus W. Distribution of natural and synthetic estrogenic steroid hormones in water samples from southern and middle Germany. Acta Hydrochim Hydrobiol 2001;29:227-41 (Pubitemid 34018469)
11. Ternes T. Occurence of drugs in German sewage treatment plants and rivers. Water Res 1998;32:3245-60 (Pubitemid 28473035)
12. Ahrer W, Scherwenk E, Buchberger W. Occurence and fate of fluoroquinolone, macrolide, and sulphonamide antibiotics during wastewater treatment and in ambient waters in Switzerland. In: Daughton CG, Jones-Lepp T, editors. Pharmaceuticals and personal care products in the environment: scientific and regulatory issues. Symposium Series American Chemical Society; Washington DC: 2001. p. 56-69
13. Heberer T. Tracking persistent pharmaceutical residues from municipal sewage to drinking water. J Hydrol 2002;266:175-89
14. Rabiet M, Togola A, Brissaud F, et al. Consequence of wastewater disposal on the contamination of the water ressource by pharmaceuticals in a Mediterranean basin. Environ Sci Technol 2006;40:5282-8
15. Zuccato E, Calamari D, Natangelo M, et al. Presence of therapeutic drugs in the environment. Lancet 2000;355:1789-90 (Pubitemid 30265087)
16. Frick EA, Henderson AK, Moll DM, et al. Presented at the Georgia Water Resources Conference; Athens, GA; 2001
17. Tauber R. Quantitative analysis of pharmaceuticals in drinking water from ten Canadian cities. Enviro-Test Laboratories; Winnipeg, Manitoba: 2003
18. Loraine GA, Pettigrove ME. Seasonal variations in concentrations of pharmaceuticals and personal care products in drinking water and reclaimed wastewater in Southern California. Environ Sci Technol 2006;40:687-95 (Pubitemid 43222148)
19. Ye Z, Weinberg HS, Meyer MT. Presented at NGWA 4th International Conference on Pharmaceuticals and Endocrine Disrupting Chemicals in Water; Minneapolis, MN; 2004
20. European Commission, Directive 2006/121/EC of the European Parliament and of the Council of 18 December 2006 amending Council Directive 67/548/EEC on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances in order to adapt it to Regulation (EC) No. 1907/2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) and establishing a European Chemicals Agency. Off. J. Eur. Union, L 396/850 of 30.12.2006, Office for Official Publications of the European Communities (OPOCE), Luxembourg, 2006
21. EMEA (2006) Guideline on the environmental impact assessment of medicinal products for human use. European Agency for the Evaluation of Medicinal Products, London, UK (Report no. CPMP/SWP/4447/00)
22. FDA-CDER. Guidance for industry-Environmental assessment of human drugs and biologics applications, Revision 1 FDA Center for Drug Evaluation and Research; Rockville 1998.
23. Food and Drug Administration Center for Drug Evaluation and Research (CDER). Guidance for industry for the submission of an environmental assessment in human drug applications and supplements. Food and Drug Administration. November, CMC 6, 1995
24. Boxall ABA, Kolpin D, Halling Sørensen B, et al. Are veterinary medicines causing environmental risks. Environ Sci Technol 2003;36:286-94
25. European Commission Technical Guidance Document in Support of Commission Directive 93/67/EEC, 2003, on Risk Assessment for NewNotified Substances, Commission Regulation (EC) No1488/94 on Risk Assessment for Existing Substances, and Directive 98/8/EC of the European Parliament and of the Council Concerning the Placing of Biocidal Products on the Market; Office for Official Publications of the European Communities. Available from: http://ecb.jrc.it/
26. Knacker T, Duis K, Ternes T, et al. The EU-project ERAPharmsIncentives for the further development of guidance documents? Environ Sci Pollut Res 2005;12:62-5 (Pubitemid 40451940)
27. FDA: U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), 1998, CMC 6 - Revision 1
28. Cleuvers M. Aquatic ecotoxicology of selected pharmaceutical agents algal and acute Daphnia tests. UWSE-Z Umweltchem Ö kotox. 2002;14:85-9 (Pubitemid 34764193)
29. Available from http://www.jpma.or.jp/english/parj/1003.html.
30. Available from www.fass.se
31. EMEA: Environmental impact assessment for veterinary medicinal products in support of the VICH guidelines GL6 (Phase I) and GL38 (Phase II). European Agency for the Evaluation of Medicinal Products, London, UK (Report no. EMEA/CVMP/ERA/418282/2005-corr), 2007
32. VICH (2004) Environmental impact assessment (EIAs) for veterinary medicinal products (VMPs)-Phase II, Draft Guidance, August, 2003, International Cooperation on Harmonization of the Technical Requirements for Registration of Veterinary Medicinal Products. Available from: http://vich.eudra.org/pdf/10- 2003/g138-st4.pdf
33. Li D, Yang M, Hu J, et al. Determination and fate of oxytetracycline and related compounds in oxytetracycline production wastewater and the receiving river. Environ Toxicol Chem 2008;27:80-6
34. Available from www.start-project.de.
35. Seehusen DA, Edwards J. Patient practices and beliefs concerning disposal of medications. J Am Board Fam Med 2006;19:542-7 (Pubitemid 44736809)
36. Kreuzig R, Holtge S, Brunotte J, et al. Test plat studies on runoff of sulfonamides from manured soil after sprinkler irrigation. Environ Toxicol Chem 2005;24:777-81 (Pubitemid 40404544)
37. Serrano PH. Responsible Use of Antibiotics in Aquaculture. Fisheries Technical Paper 469. Food and Agriculture Organization of the United Nations (FAO); Rome: 2005
38. Available from http://www.apsnet.org/online/feature/Antibiotics/
39. Available from http://www.esac.ua.ac.be/main.aspx?c=*ESAC2&n= 1066l
40. Xu WH, Zhang G, Zou SC, et al. Determination of selected antibiotics in the Victoria Harbour and the Pearl River, South China using high-performance liquid chromatography electrospray ionization tandem mass spectrometry. Environ Pollut 2007;145:672-9 (Pubitemid 46149173)
41. Ye Z, Weinberg HS, Meyer MT. Trace analysis of trimethoprim and sulfonamide, macrolide, quinolone, and tetracycline antibiotics in chlorinated drinking water using liquid chromatography electrospray tandem mass spectrometry. Anal Chem 2007;79:1135-44
42. Kim SC, Carlson K. Temporal and spatial trends in the occurrence of human and veterinary antibiotics in aqueous and river sediment matrices. Environ Sci Technol 2007;41:50-7 (Pubitemid 46047822)
43. Martinez-Carballo E, Gonzalez-Barreiro C, Scharf S, et al. Environmental monitoring study of selected veterinary antibiotics in animal manure and soils in Austria. Environ Pollut 2007;148:570-9 (Pubitemid 46818655)
44. Hamscher G, Sczesny S, Hoper H, et al. Determination of persistent tetracycline residues in soil fertilized with liquid manure by high-performance liquid chromatography with electrospray ionization tandem mass spectrometry. Anal Chem 2002;74:1509-18 (Pubitemid 34297584)
45. Hamscher G, Pawelzick HT, Sczesny S, et al. Antibiotics in dust originating from a pig fattening farm: a new source of health hazard for farmers? Environ Health Perspect 2003;111:1590-4 (Pubitemid 37265968)
46. Kummerer K, Alexy R, Huttig J. Standardized tests fail to assess the effects of antibiotics on environmental bacteria. Water Res 2004;38:2111-16 (Pubitemid 38496210)
47. Carucci A, Cappai G, Piredda M. Biodegradability and toxicity of pharmaceuticals in biological wastewater treatment plants. Environ Sci Health A Tox Hazard Subst Environ Eng 2006;41:1831-42 (Pubitemid 44124805)
48. Hernando MD, DeVettori S, Martinez-Bueno MJ, et al. Toxicity evaluation with Vibrio fisheri test of organic chemicals used in aquaculture. Chemosphere 2007;68:724-30 (Pubitemid 46590282)
49. Thomulka KW, McGee DJ. Detection of biohazardous materials in water by measuring bioluminescence reduction with the marine organism Vibrio harveyi. Environ Sci Health A 1993;28:2153-66
50. Halling-Sørensen B. Algal toxicity of antibacterial agents used in intensive farming. Chemosphere 2000;40:731-9 (Pubitemid 30085795)
51. Brain RA, Hanson ML, Solomon KR, et al. Aquatic plants exposed to pharmaceuticals: effects and risks. Rev Environ Contam Toxicol 2008;192:67-115
52. Sengelov G, Agerso Y, Halling-Sørensen B, et al. Bacterial antibiotic resistance levels in farmland as a result of treatment with pig slurry. Environ Int 2001;28:587-95 (Pubitemid 36104884)
53. Hansen AJ, Jensen J, Krogh PH. Effects of the antibiotics oxytetracycline and tylosin on soil fauna. Chemosphere 2000;40:751-7 (Pubitemid 30085797)
54. Holt D, Harvey D, Hurley R. Chloramphenicol toxicity. Adverse Drug React Toxicol Rev 1993;12:83-95 (Pubitemid 23222558)
55. Takai H, Pedersen S, Johnsen JO, et al. Concentrations and emissions of airborne dust in livestock buildings in northern Europe. J Agric Eng Res 1998;70:59-77 (Pubitemid 128644534)
56. Salyers AA. An overview of the genetic basis of antibiotic resistance in bacteria and its implications for agriculture. Anim Biotechnol 2002;13:1-5.
57. Schluter A, Szczepanowski R, Puhler A. Genomics of IncP-1 antibiotic resistance plasmids isolated from wastewater treatment plants provides evidence for a widely accessible drug resistance gene pool. FEMS Microbiol Rev 2007;31:449-77 (Pubitemid 46920252)
58. Harrison PF, Lederberg J. Antimicrobial Resistance, Issues and Options. National Academic Press; Washington DC: 1998
59. Huggett DB, Brooks BW, Peterson B, et al. Toxicity of select beta adrenergic receptor-blocking pharmaceuticals (betablockers) on aquatic organisms. Arch Environ Contam Toxicol 2002;43(2):229
60. Haider S, Baqri SSR. beta-Adrenoceptor antagonists reinitiate meiotic maturation in Clarias batrachus oocytes. Comp Biochem Physiol A 2000;126(4):517
61. Warbrick EV, Ward SA. The effect of catecholamines and catecholamine antagonists on the third larval moult of Dirofilaria immitis in vitro. J Helminthol 1992;66:273-8 (Pubitemid 23052562)
62. Ohnishi ST, Sadanaga KK, Katsuoka M, et al. Effects of membrane acting-drugs on Plasmodium species and sickle cell erythrocytes. Mol Cell Biochem 1989;91:159-65 (Pubitemid 20007144)
63. Coppi A, Merali S, Eichinger D. The enteric parasite Entamoeba uses an autocrine catecholamine system during differentiation into the infectious cysts stage. J Biol Chem 2002;277:8083-90 (Pubitemid 34968262)
64. Nunes B, Carvalho F, Guilhermino L. Acute and chronic effects of clofibrate and clofibric acid on the enzymes acetylcholinesterase, lactate dehydrogenase and catalase of the mosquitofish, Gambusia holbrooki. Chemosphere 2004;57(11):1581-9 (Pubitemid 39424996)
65. Ferrari B, Paxeus N, Lo Giudice R, et al. Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotoxicol Environ Saf 2003;55(3):359-70 (Pubitemid 36683194)
66. Santamarina MT, Leiro J, Vilanova R, et al. The immunosuppressive effect of clofibrate and cyclosporine on IgM and IgE antibodies induced by Trichinella spiralis. Rev Ibero Parasitol 1987;47:289-93
67. Misra SK, Sharma AK, Mehdi H, et al. Effect of cholesterol and alphapchlorophenoxyisobutyyrate on virulence in Acanthamoeba culbertsoni strain A-1 and C-7. Int J Parasitol 1986;16:191-6 (Pubitemid 16058253)
68. Vandewaa EA, Mills G, Chen GZ, et al. Physiological role ofHMG-CoAreductase in regulating egg production by Schistosoma mansoni. Am J Physiol Regul Integr Comp Physiol 1989;257:618-25
69. Schwabe U, Paffrath D. Arzneiverordnungsreport. Springer Verlag; Berlin, Germany: 2003
70. Cleuvers M. Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen and acetylsalicylic acid. Ecotoxicol Environ Saf 2004;59:309-15 (Pubitemid 39243972)
71. Oaks JL, Gilbert M, Virani MZ, et al. Diclofenac residues as the cause of population decline of vultures in Pakistan. Nature 2004;427:630-3 (Pubitemid 38248481)
72. Ferrari B, Mons R, Vollat B, et al. Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment? Environ Toxicol Chem 2004;23(5):1344-54 (Pubitemid 38621043)
73. Schwaiger J, Ferling H, Mallow U, et al. Toxic effects of the non-steroidal antiinflammatory drug diclofenac: part I: histopathological alterations and bioaccumulation in rainbow trout. Aquat Toxicol 2004;68(2):141
74. Boroskova Z, Dvoroznakova E, Tomasovicova O, et al. The effect of cyclophosphamide on the cellular and humoral immune responses on experimental Toxocara canis infestation. Helminthologia 2001;38:193-9 (Pubitemid 33679212)
75. Warren KS. Studies on the treatment of molluscan Schistosomiasis mansoni with antibiotics, non-antibiotic metabolic inhibitors, molluscicides and antischistosomal agents. Trans R Soc Trop Med Hyg 1967;61:368-72
76. Miguel DC, Yokoyama-Yasunaka JKU, Andreoli WK, et al. Tamoxifen is effective against Leishmania and induces a rapid alkalinization of parasitophorous vacuoles harbouring Leishmania (Leishmania) amazonensis amastigotes. J Antimicrob Chemother 2007;60:526-34 (Pubitemid 47299866)
77. Ellenberger TE, Wright JE, Rosowsky A, et al. Wild-type and drugresistant Leishmania major hydrolyze methotrexate to N-10-methyl-4-deoxy-4-aminopteroate without accumulation of methotrexate polyglutamates. J Biol Chem 1989;264:15960-6 (Pubitemid 19238353)
78. Henschel KP, Wenzel A, Diedrich M, et al. Environmental hazard assessment of pharmaceuticals. Regul Toxicol Pharm 1997;25(3):220
79. Harwood PD. The anthelmintic properties of phenothiazine. Exp Parasitol 1953;2:428-55
80. Boyle JP, Yoshino TP. Serotonin-induced muscular activity in Schistosoma mansoni larval stages: importance of 5-HT transport and role in daughter sporocyst production. J Parasitol 2005;91:542-50 (Pubitemid 40993440)
81. Baqui A, Ansari JA. Investigations on the response to various stimuli of the microfilariae of Setaria cervi in white rats. Helminthologia 1987;24:33-42
82. Jones-Brando L, Torrey EF, Yolkem R. Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophr Res 2003;62:237-44 (Pubitemid 36775365)
83. Jobling S, Tyler CR. Endocrine disruption, parasites and pollutants in wild freshwater fish. Parasitology 2003;126:103-8
84. El-Gowhary SH, Rahmy AE, El-Azzouni MZ, et al. Oral contraceptive pills in experimental Schistosomiasis mansoni: parasitological, biochemical, histopathological and ultrastructural studies. J Egypt Soc Parasitol 1993;23:609-19
85. Pung OJ, Luster MI. Toxoplasma gondii, decreased resistance to infection in mice due to estrogen. Exp Parasitol 1986;61:48-56 (Pubitemid 16166833)
86. Arcay L. Influence of sex hormones on the experimental infection produced by a strain of Leishmania mexicana amazonensis from Venezuela. Rev Latinoam Microbiol 1985;27:195-207
87. Wang R, Belosevic M. Estradiol increases susceptibility of goldfish to trypanosoma danilewskyi. Dev Comp Immunol 1994;18:377-87 (Pubitemid 24379412)
88. Serrano DR, Zanotti-Magalhaes EM, Magalhaes LA, et al. Influencia da hidrocortisona no desenvolvimento do Schistosoma mansoni em Biomphalaria glabrata. Rev Soc Bras Med Trop 2002;35:149-53 (Pubitemid 34453443)
89. Boxall AB, Fogg LA, Baird DJ, et al. Targeted monitoring study for veterinary medicines in the environment. Environment Agency; Bristol, UK: 2005. p. 119
90. Kozuh Erzen N, Kolar L, Cerkvenik Flajs V, et al. Degradation of abamectin and doramectin on sheep grazed pasture. Ecotoxicology 2005;14:627-35 (Pubitemid 41426245)
91. Grønvold J, Svendsen TS, Kraglund HO, et al. Effect of the antiparasitic drugs fenbendazole and ivermectin on the soil nematode Pristionchus maupasi. Vet Parasitol 2004;124:91-9 (Pubitemid 39179995)
92. Halley BA, Winter R, Yoon S, et al. The environmental safety of eprinomectin to earthworms. Vet Parasitol 2005;128:109-14 (Pubitemid 40255880)
93. Sun Y, Diao X, Zhang Q, et al. Bioaccumulation and elimination of avermectin B1a in the earthworm (Eisenia fetida). Chemosphere 2005;60:699-704 (Pubitemid 40814395)
94. Yoshimura H, Endoh YS, Harada K. Gryllus bimaculatus: a possible bioindicator organism for detection of chemical pollutants in terrestrial systems. Ecol Indicator 2005;5:181-8 (Pubitemid 41537159)
95. Svendsen TS, Hansen PE, Sommer C, et al. Life history characteristics of Lumbricus terrestris and effects of the veterinary antiparasitics compounds Ivermectin and fenbendazole. Soil Biol Biochem 2005;37:927-36 (Pubitemid 40307274)
96. Singer AC, Johnson AC, Anderson PD. Reassessing the risks of Tamiflu use during a pandemic to the Lower Colorado River. Environ Health Perspect 2008;116:A285-6
97. Soderstrom H, Jarhult JD, Fick J, et al. Levels of antivirals and antibiotics in the river Thames, UK, during the pandemic 2009. SETAC Europe Annual Meeting; Seville; 2010
98. Flaherty CM, Dodson SI. Effects of pharmaceuticals on Daphnia survival, growth, and reproduction. Chemosphere 2005;61:200-7 (Pubitemid 41317134)
99. Pomati F, Castiglioni S, Zuccato E, et al. Effects of a complex mixture of therapeutic drugs at environmental levels on human embryonic cells. Environ Sci Technol 2006;40:2442-7
100. Calow P, Forbes VE. Does ecotoxicology inform ecological risk assessment? Environ Sci Technol 2003;37:146A-51A (Pubitemid 36504932)
101. Johnston JJ, Savarie PJ, Primus TM, et al. Risk assessment of an acetaminophen baiting program for chemical control of brown tree snakes on Guam: evaluation of baits, snake residues, and potential primary and secondary hazards. Environ Sci Technol 2002;36:3827-33 (Pubitemid 35006338)
102. Kummerer K. Sustainable from the very beginning: rational design of molecules by life cycle engineering as an important approach for green pharmacy and green chemistry. Green Chem 2007;9:899-7
103. Nowotny N, Epp B, Von Sonntag C. Quantification and modeling of the elimination behavior of ecologically problematic wastewater micropollutants by adsorption on powdered and granulated activated carbon. Environ Sci Technol 2007;41:2050-5 (Pubitemid 46449241)
104. Selassie CD. History of quantitative structure-activity relationships. Burger's Medicinal Chemistry and Drug Discovery. In: Abraham DJ, editor. John Wiley; New York, USA: 2003. p. 1-48
105. Tropsha A. Best Practices for QSAR Model Development, Validation, and Exploitation. Mol Infect 2010;29:476-88
106. Roy K, Mitra I. On Various Metrics Used for Validation of Predictive QSAR Models with Applications in Virtual Screening and Focused Library Design. Comb Chem High Throughput Screen 2011;14:450-74
107. Wold S, Eriksson L. Validation tools. In: van de Waterbeemd H, editor. Chemometric methods in molecular design. VCH; Weinheim, Ger: 1995. p. 312-17
108. Ojha PK, Mitra I, Das RN, et al. Further exploring rm2 metrics for validation of QSPR models. Chemom Intell Lab Syst 2011;107:194
109. Hopfinger AJ, Wang S, Tokarski JS. Construction of 3D-QSAR models of prostaglandins using the 4d-qsar analysis formalism. J Am Chem Soc 1997;119:10509-24 (Pubitemid 27487990)
110. Available from http://www.dddmag.com/qsar-prediction-beyond-the-fourth. aspx
111. Available from http://www.modeling. unibas.ch/UB-BB2.html
112. Kristam R, Gillet VJ, Lewis RA, et al. Comparison of conformational analysis techniques to generate pharmacophore hypotheses using catalyst. J Chem Inf Model 2005;45:461-76 (Pubitemid 40635354)
113. Available from http://ec.europa.eu/research/biosociety/pdf/anim-al-see- final-report.pdf
114. Cronin MTD, Livingstone DJ. Predicting chemical toxicity and fate. CRC press; Washington DC: 2004
115. Available from http://www.oecd.org/officialdocuments/displaydocumentpdf
116. Kar S, Roy K. First report on interspecies quantitative correlation of ecotoxicity of pharmaceuticals. Chemosphere 2010;81:738-47
117. Sanderson H, Thomsen M. Comparative analysis of pharmaceuticals versus industrial chemicals acute aquatic toxicity classification according to the United Nations classification system for chemicals. Assessment of the (Q)SAR predictability of pharmaceuticals acute aquatic toxicity and their predominant acute toxic mode-of-action. Toxicol Lett 2009;187:84-93
118. Berninger JP, Brooks BW. Leveraging mammalian pharmaceutical toxicology and pharmacology data to predict chronic fish responses to pharmaceuticals. Toxicol Lett 2010;193(1):69-78
119. Sanderson H, Thomsen M. Ecotoxicological quantitative structure-activity relationships for pharmaceuticals. Bull Environ Contam Toxicol 2007;79:331-5 (Pubitemid 47389292)
120. Escher BI, Bramaz N, Richter M, et al. Comparative ecotoxicological hazard assessment of beta-blockers and their human metabolites using a mode-ofaction- based test battery and a QSTR approach. Environ Sci Technol 2006;40:7402-8 (Pubitemid 44871854)
121. Christen V, Hickmann S, Rechenberg B, et al. Highly active human pharmaceuticals in aquatic systems: a concept for their identification based on their mode of action. Aquat Toxicol 2010;96:167-81
122. Available from http://www.biograf.ch
123. Escher BI, Baumgartner R, Koller M, et al. Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater. Water Res 2011;45:75-92
124. Verenitch SS, Lowe CJ, Mazumder A. Determination of acidic drugs and caffeine in municipal wastewaters and receiving waters by gas chromatography-ion trap tandem mass spectrometry. J Chromatogr A 2006;1116:193-03
125. Bendz D, Paxeus NA, Ginn TR, et al. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Hoje River in Sweden. J Hazard Mater 2005;122:195-04
126. Calamari D, Zuccato E, Castiglioni S, et al. Strategic survey of therapeutic drugs in the Rivers Po and Lambro in Northern Italy. Environ Sci Technol 2003;37:1241-8 (Pubitemid 36504934)
127. Barnes KK, Kolpin DW, Furlong ET, et al. A national reconnaissance of pharmaceuticals and other organic wastewater contaminants in the United States-I) Groundwater. Sci Total Environ 2008;402:192-200
128. Pounds N, Maclean S, Webley M, et al. Acute and chronic effects of ibuprofen in the mollusc Planorbis carinatus (Gastropoda: Planorbidae). Ecotoxicol Environ Saf 2008;70:47-52
129. Hernando MD, Heath E, Petrovic M, et al. Trace-level determination of pharmaceuticals residues by LC-MS/MS in natural and treated waters. A pilotsurvey study. Anal Bioanal Chem 2006;385:985-91 (Pubitemid 43992153)
130. Kim JW, Ishibashi H, Yamauchi R, et al. Acute toxicity of pharmaceutical and personal care products on freshwater crustacean (Thamnocephalus platyurus) and fish (Oryzias latipes). J Toxicol Sci 2009;34:227-32
131. Isidori M, Lavorgna M, Nardelli A. Ecotoxicity of naproxen and its phototransformation products. Sci Total Environ 2005;48:93-101 (Pubitemid 41267227)
132. Kim Y, Choi K, Jung J, et al. Aquatic toxicity of acetaminophen, carbamazepine, cimetidine, diltiazem and six major sulfonamides, and their potential ecological risks in Korea. Environ Int 2007;33:275-370
133. Quinn B, Gagne F, Blaise C. An investigation into the acute and chronic toxicity of eleven pharmaceuticals (and their solvents) found in wastewater effluent on the cnidarian, Hydra attenuate. Sci Total Environ 2008;389:306-14 (Pubitemid 350101743)
134. Zurita JL, Repetto G, Jos A, et al. Toxicological effects of the lipid regulator gemfibrozil in four aquatic systems. Aquat Toxicol 2007;81:106-15 (Pubitemid 46080492)
135. Miao XS, Metcalfe CD. Determination of cholesterol-lowering statin drugs in aqueous samples using liquid chromatography-electrospray ionization tandem mass spectrometry. J Chromatogr A 2003;998:133-41 (Pubitemid 36629467)
136. Park S, Choi K. Hazard assessment of commonly used agricultural antibiotics on aquatic ecosystems. Ecotoxicology 2008;17:526-38
137. Heckamann LH, Callaghan A, Hooper HL, et al. Chronic toxicity of ibuprofen to Daphnia magna: effects on life history traits and population dynamics. Toxicol Lett 2007;172:137-45 (Pubitemid 47187597)
138. Isidori M, Lavorgna M, Nardelli A, et al. Toxic and genotoxic evaluation of six antibiotics on non-target organisms. Sci Total Environ 2005;346:87-98 (Pubitemid 40931920)
139. Zuehlke S, Duennbier U, Heberer T. Determination of estrogenic steroids in surface water and wastewater by liquid chromatography-electrospray tandem mass spectrometry. J Sep Sci 2005;28:52-8 (Pubitemid 40214465)
140. Vulliet E, Wiest L, Baudot R, et al. Multi-residue analysis of steroids at sub-ng/L levels in surface and ground-waters using liquid chromatography coupled to tandem mass spectrometry. J Chromatogr A 2008;1210:84-91
141. Pawlowski S, van Aerle R, Tyler CR, et al. Effects of 17alpha- ethinylestradiol in a fathead minnow (Pimephales promelas) gonadal recrudescence assay. Ecotoxicol Environ Saf 2004;57:330-45 (Pubitemid 38376267)
142. Winter MJ, Lillicrap AD, Caunter JE, et al. Defining the chronic impacts of atenolol on embryo-larval development and reproduction in the fathead minnow (Pimephales promelas). Aquat Toxicol 2008;86:361-9
143. Pery ARR, Gust M, Vollat B, et al. Fluoxetine effects assessment on the life cycle of aquatic invertebrates. Chemosphere 2008;73:300-4
144. Vasskog T, Anderssen T, Pedersen-Bjergaard S, et al. Occurrence of selective serotonin reuptake inhibitors in sewage and receiving waters at Spitsbergen and in Norway. J Chromatogr A 2008;1185:194-05
145. Grung M, Kallqvist T, Sakshaug S, et al. Environmental assessment of Norwegian priority pharmaceuticals based on the EMEA guideline. Ecotoxicol Environ Saf 2008;71:328-40